A phase 2 trial shows that olpasiran, an RNA-based therapy, reduces lipoprotein(a) [Lp(a)] levels by more than 95% in ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...
They say that change takes time. Well, that's not the case for RNA. The small biological molecule acts like a switchboard ...
Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...
BOISE — Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in ...
Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho on Monday but did not take a vote.
The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to ...
The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and ...
There are many molecules with therapeutic potential, but it can be a challenge to deliver them to the right places at the ...
New research suggests that the formation of stress granules, clumps of proteins and RNA under stress, is a potential root ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results